1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA PHF2 CTRPv2 pan-cancer AAC 0.16 8e-07
mRNA RCOR2 CTRPv2 pan-cancer AAC 0.18 8e-07
mRNA FSD1L CTRPv2 pan-cancer AAC 0.16 8e-07
mRNA SEC11A CTRPv2 pan-cancer AAC -0.16 8e-07
mRNA MANBAL CTRPv2 pan-cancer AAC -0.21 8e-07
mRNA RP13-512J5.1 CTRPv2 pan-cancer AAC -0.16 8e-07
mRNA TOP2B CTRPv2 pan-cancer AAC 0.18 8e-07
mRNA HMX2 CTRPv2 pan-cancer AAC 0.16 9e-07
mRNA MDM4 CTRPv2 pan-cancer AAC 0.19 9e-07
mRNA ZNF608 CTRPv2 pan-cancer AAC 0.16 9e-07
Download CSV